Nicholas P. van der Meulen - Search Results

Year	Number of Results
2015	1
2016	7
2017	9
2018	4
2019	11
2020	8
2021	14
2022	6
2023	9
2024	2

1

First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([¹⁶¹Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum.

Fricke J, Westerbergh F, McDougall L, Favaretto C, Christ E, Nicolas GP, Geistlich S, Borgna F, Fani M, Bernhardt P, van der Meulen NP, Müller C, Schibli R, Wild D. Fricke J, et al. Among authors: van der meulen np. Eur J Nucl Med Mol Imaging. 2024 Mar 7. doi: 10.1007/s00259-024-06641-w. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38448550 No abstract available.

2

Preclinical Evaluation of Gastrin-Releasing Peptide Receptor Antagonists Labeled with ¹⁶¹Tb and ¹⁷⁷Lu: A Comparative Study.

Holzleitner N, Cwojdzinski T, Beck R, Urtz-Urban N, Hillhouse CC, Grundler PV, van der Meulen NP, Talip Z, Ramaekers S, Van de Voorde M, Ponsard B, Casini A, Günther T. Holzleitner N, et al. Among authors: van der meulen np. J Nucl Med. 2024 Mar 1;65(3):481-484. doi: 10.2967/jnumed.123.266233. J Nucl Med. 2024. PMID: 38124121

3

Synthesis and Preclinical Evaluation of Radiolabeled [¹⁰³Ru]BOLD-100.

Happl B, Brandt M, Balber T, Benčurová K, Talip Z, Voegele A, Heffeter P, Kandioller W, Van der Meulen NP, Mitterhauser M, Hacker M, Keppler BK, Mindt TL. Happl B, et al. Among authors: van der meulen np. Pharmaceutics. 2023 Nov 15;15(11):2626. doi: 10.3390/pharmaceutics15112626. Pharmaceutics. 2023. PMID: 38004604 Free PMC article.

4

Study of thulium-167 cyclotron production: a potential medically-relevant radionuclide.

Renaldin E, Dellepiane G, Braccini S, Sommerhalder A, Zhang H, van der Meulen NP, Eichler R, Talip Z. Renaldin E, et al. Among authors: van der meulen np. Front Chem. 2023 Oct 19;11:1288588. doi: 10.3389/fchem.2023.1288588. eCollection 2023. Front Chem. 2023. PMID: 37927558 Free PMC article.

5

Cross-section measurement of thulium radioisotopes with an 18 MeV medical PET cyclotron for an optimized ¹⁶⁵Er production.

Dellepiane G, Casolaro P, Favaretto C, Gottstein A, Grundler PV, Mateu I, Renaldin E, Scampoli P, Talip Z, van der Meulen NP, Braccini S. Dellepiane G, et al. Among authors: van der meulen np. Appl Radiat Isot. 2023 Oct;200:110954. doi: 10.1016/j.apradiso.2023.110954. Epub 2023 Jul 24. Appl Radiat Isot. 2023. PMID: 37527621 Free article.

6

Corrigendum to "Determination of the gamma and X-ray emission intensities of terbium-161" [Appl. Radiat. Isot. 174 (2021) 109770].

Juget F, Talip Z, Buchillier T, Durán MT, Nedjadi Y, Desorgher L, Bochud F, Grundler P, van der Meulen NP, Bailat C. Juget F, et al. Among authors: van der meulen np. Appl Radiat Isot. 2023 Oct;200:110955. doi: 10.1016/j.apradiso.2023.110955. Epub 2023 Jul 27. Appl Radiat Isot. 2023. PMID: 37516578 No abstract available.

7

Albumin-Binding and Conventional PSMA Ligands in Combination with ¹⁶¹Tb: Biodistribution, Dosimetry, and Preclinical Therapy.

Tschan VJ, Busslinger SD, Bernhardt P, Grundler PV, Zeevaart JR, Köster U, van der Meulen NP, Schibli R, Müller C. Tschan VJ, et al. Among authors: van der meulen np. J Nucl Med. 2023 Oct;64(10):1625-1631. doi: 10.2967/jnumed.123.265524. Epub 2023 Jul 13. J Nucl Med. 2023. PMID: 37442604

8

Opportunities and potential challenges of using terbium-161 for targeted radionuclide therapy in clinics.

Müller C, van der Meulen NP, Schibli R. Müller C, et al. Among authors: van der meulen np. Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3181-3184. doi: 10.1007/s00259-023-06316-y. Eur J Nucl Med Mol Imaging. 2023. PMID: 37436459 No abstract available.

9

¹⁶¹Tb-DOTATOC Production Using a Fully Automated Disposable Cassette System: A First Step Toward the Introduction of ¹⁶¹Tb into the Clinic.

Favaretto C, Grundler PV, Talip Z, Landolt S, Sepini L, Köster U, Müller C, Schibli R, Geistlich S, van der Meulen NP. Favaretto C, et al. Among authors: van der meulen np. J Nucl Med. 2023 Jul;64(7):1138-1144. doi: 10.2967/jnumed.122.265268. Epub 2023 May 18. J Nucl Med. 2023. PMID: 37201956 Free PMC article.

10

A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptides.

Beyer D, Vaccarin C, Deupi X, Mapanao AK, Cohrs S, Sozzi-Guo F, Grundler PV, van der Meulen NP, Wang J, Tanriver M, Bode JW, Schibli R, Müller C. Beyer D, et al. Among authors: van der meulen np. EJNMMI Res. 2023 Apr 19;13(1):32. doi: 10.1186/s13550-023-00979-2. EJNMMI Res. 2023. PMID: 37074529 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

65 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year